An observational study in Steatoblepharon, sponsored by Topokine Therapeutics, Inc.. Completed. Open to participants aged 25 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-12-02.
Sponsored by Topokine Therapeutics, Inc. · Observational
This observational study will test the inter-rater and test-retest reliability of the LESS scale in a live context.
Topokine Therapeutics, Inc. is the lead sponsor of 7 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Eligible adults with varying degrees of lower eyelid steatoblepharon
Exclusion Criteria:
LESS score (Clinician-Reported)
Time frame: Eyelids will be assessed on one day only (cross-sectional study)
No study locations are listed for this record.
This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Topokine Therapeutics, Inc.